Anti-fungal Agents Flashcards
Patients that are a higher risk of developing a nosocomial systemic mycoses
Surgical and intensive care; prosthetics; immunosuppressed
What is the primary target in anti-fungal drugs?
Ergosterol biosynthesis
Squalene is converted to lanosterol by
squalene epoxidase
Lanosterol is converted to ergosterol by
14-alpha-sterol demethylase
Allylamines block which enzyme?
Squalene epoxidase
Azoles inhibit which enzyme
14-alpha-sterol demethylase
What does a fungal cell wall contain?
Chitin, Beta-D-glucans, glycoproteins
What is the structure of amphotericin B?
Amphoteric polyene macrolide
How does the structure of amphotericin affect its PKs?
low solubility and poor oral absorption
How does the MOA of amphotericin affect the fungal pathogens?
Binds to ergosterol and disrupts the membrane stability by forming pores
When is amphotericin used?
life-threatening mycoses due to toxicity
What are the toxic effects of amphotericin?
Cytokine storm; renal toxicity (renal ischemia and proximal tubular injury); hematologic toxicity (myelosuppression)
Which anti-fungal inhibits DNA/RNA synthesis?
Flucytosine
How is flucytosine selective for fungal cells?
Cytosine permease and cytosine deaminase aren’t expressed in mammals
What is the end goal of flucytosine?
Inhibition of thymidylate synthase